| |
| |
|
| Insider
Information: |
Mahon Paul A |
| Relationship: |
|
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
36,710 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,584,634 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
36,710 |
|
|
| Total
Value |
$8,584,634 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
United Therapeutics Corp |
UTHR |
|
2024-04-04 |
36,710 |
2004-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2024-04-04 |
4 |
OE |
$117.76 |
$706,560 |
D/D |
6,000 |
42,710 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2024-04-04 |
4 |
AS |
$228.84 |
$1,394,248 |
D/D |
(6,000) |
36,710 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2024-03-21 |
4 |
AS |
$234.11 |
$1,418,726 |
D/D |
(6,000) |
36,710 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2024-03-21 |
4 |
OE |
$117.76 |
$706,560 |
D/D |
6,000 |
42,710 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2024-03-07 |
4 |
AS |
$236.90 |
$1,424,309 |
D/D |
(6,000) |
36,599 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2024-03-07 |
4 |
OE |
$117.76 |
$706,560 |
D/D |
6,000 |
42,599 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2024-02-15 |
4 |
OE |
$117.76 |
$706,560 |
D/D |
6,000 |
42,599 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2024-02-15 |
4 |
AS |
$214.54 |
$1,291,885 |
D/D |
(6,000) |
36,599 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2024-02-01 |
4 |
AS |
$213.58 |
$1,290,083 |
D/D |
(6,000) |
36,599 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2024-02-01 |
4 |
OE |
$117.76 |
$706,560 |
D/D |
6,000 |
42,599 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2024-01-18 |
4 |
AS |
$217.55 |
$1,312,322 |
D/D |
(6,000) |
36,599 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2024-01-18 |
4 |
OE |
$117.76 |
$706,560 |
D/D |
6,000 |
42,599 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2024-01-04 |
4 |
OE |
$117.76 |
$706,560 |
D/D |
6,000 |
42,599 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2024-01-04 |
4 |
AS |
$227.34 |
$1,367,798 |
D/D |
(6,000) |
36,599 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-12-21 |
4 |
AS |
$223.94 |
$1,375,605 |
D/D |
(6,000) |
36,599 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-12-21 |
4 |
OE |
$117.76 |
$706,560 |
D/D |
6,000 |
42,599 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-12-07 |
4 |
AS |
$238.88 |
$1,433,331 |
D/D |
(6,000) |
36,599 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-12-07 |
4 |
OE |
$117.76 |
$706,560 |
D/D |
6,000 |
42,599 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-11-16 |
4 |
OE |
$117.76 |
$706,560 |
D/D |
6,000 |
42,599 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-11-16 |
4 |
AS |
$226.05 |
$1,359,593 |
D/D |
(6,000) |
36,599 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-10-19 |
4 |
AS |
$224.02 |
$1,352,591 |
D/D |
(6,000) |
36,599 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-10-19 |
4 |
OE |
$117.76 |
$706,560 |
D/D |
6,000 |
42,599 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-10-05 |
4 |
AS |
$221.92 |
$1,342,923 |
D/D |
(6,000) |
36,599 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-10-05 |
4 |
OE |
$117.76 |
$706,560 |
D/D |
6,000 |
42,599 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-09-21 |
4 |
AS |
$221.38 |
$1,333,150 |
D/D |
(6,000) |
36,599 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
